266 related articles for article (PubMed ID: 8381710)
1. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study.
Major FJ; Blessing JA; Silverberg SG; Morrow CP; Creasman WT; Currie JL; Yordan E; Brady MF
Cancer; 1993 Feb; 71(4 Suppl):1702-9. PubMed ID: 8381710
[TBL] [Abstract][Full Text] [Related]
2. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
3. Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages.
Rovirosa A; Ascaso C; Ordi J; Abellana R; Arenas M; Lejarcegui JA; Pahisa J; Puig-Tintoré LM; Mellado B; Armenteros B; Iglesias X; Biete A
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1320-9. PubMed ID: 11955745
[TBL] [Abstract][Full Text] [Related]
4. Uterine sarcoma: analysis of prognostic variables in 71 cases.
Wheelock JB; Krebs HB; Schneider V; Goplerud DR
Am J Obstet Gynecol; 1985 Apr; 151(8):1016-22. PubMed ID: 2984936
[TBL] [Abstract][Full Text] [Related]
5. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence.
Goff BA; Rice LW; Fleischhacker D; Muntz HG; Falkenberry SS; Nikrui N; Fuller AF
Gynecol Oncol; 1993 Jul; 50(1):105-9. PubMed ID: 8349151
[TBL] [Abstract][Full Text] [Related]
6. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
[TBL] [Abstract][Full Text] [Related]
7. Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998.
Livi L; Andreopoulou E; Shah N; Paiar F; Blake P; Judson I; Harmer C
Clin Oncol (R Coll Radiol); 2004 Jun; 16(4):261-8. PubMed ID: 15214650
[TBL] [Abstract][Full Text] [Related]
8. Uterine sarcomas: a clinicopathologic study, 1965-1981.
Marchese MJ; Liskow AS; Crum CP; McCaffrey RM; Frick HC
Gynecol Oncol; 1984 Jul; 18(3):299-312. PubMed ID: 6086468
[TBL] [Abstract][Full Text] [Related]
9. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.
Vongtama V; Karlen JR; Piver SM; Tsukada Y; Moore RH
AJR Am J Roentgenol; 1976 Jan; 126(1):139-47. PubMed ID: 175673
[TBL] [Abstract][Full Text] [Related]
10. Autopsy findings in patients with uterine sarcoma.
Fleming WP; Peters WA; Kumar NB; Morley GW
Gynecol Oncol; 1984 Oct; 19(2):168-72. PubMed ID: 6489828
[TBL] [Abstract][Full Text] [Related]
11. Uterine sarcomas.
Mbatani N; Olawaiye AB; Prat J
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
[TBL] [Abstract][Full Text] [Related]
12. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
[TBL] [Abstract][Full Text] [Related]
13. [Uterine sarcoma in Tunisia: retrospective study about 14 cases].
Bouzid N; Kanoun Belajouza S; Boussen H; Bouaouina N
Gynecol Obstet Fertil; 2014 Dec; 42(12):838-43. PubMed ID: 25155830
[TBL] [Abstract][Full Text] [Related]
14. Sarcomas of the uterus: a clinicopathologic study of 119 patients.
Kahanpää KV; Wahlström T; Gröhn P; Heinonen E; Nieminen U; Widholm O
Obstet Gynecol; 1986 Mar; 67(3):417-24. PubMed ID: 3945454
[TBL] [Abstract][Full Text] [Related]
15. Uterine sarcomas.
Punnonen R; Lauslahti K; Pystynen P; Kauppila O
Ann Chir Gynaecol Suppl; 1985; 197():11-4. PubMed ID: 3863523
[TBL] [Abstract][Full Text] [Related]
16. Uterine sarcoma: a clinicopathological study of 93 cases.
González-Bosquet E; Martínez-Palones JM; González-Bosquet J; García Jiménez A; Xercavins J
Eur J Gynaecol Oncol; 1997; 18(3):192-5. PubMed ID: 9174834
[TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.
Omura GA; Blessing JA; Major F; Lifshitz S; Ehrlich CE; Mangan C; Beecham J; Park R; Silverberg S
J Clin Oncol; 1985 Sep; 3(9):1240-5. PubMed ID: 3897471
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and treatment modalities in uterine sarcoma.
El Husseiny G; Al Bareedy N; Mourad WA; Mohamed G; Shoukri M; Subhi J; Ezzat A
Am J Clin Oncol; 2002 Jun; 25(3):256-60. PubMed ID: 12040283
[TBL] [Abstract][Full Text] [Related]
19. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
[TBL] [Abstract][Full Text] [Related]
20. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
D'Angelo E; Spagnoli LG; Prat J
Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]